Search for: "Pfizer"
Results 1101 - 1120
of 4,624
Sort by Relevance
|
Sort by Date
13 Jan 2020, 12:04 pm
” The newspaper pointed out that other CR award winners included “the Gap and Nike (famous for using sweatshop workers), tobacco giant Altria (which owns Marlboro cigarettes), big banks including CitiGroup and Goldman Sachs, pharmaceutical giants such as Merck, Pfizer, and Johnson & Johnson, and even carbon-polluting power and oil companies, including XCEL Energy and ConocoPhillips. [read post]
13 Jan 2020, 12:04 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
10 Jan 2020, 9:32 am
Pfizer Pharmaceuticals, LLC, 730 F.3d 49 (1st Cir. 2013) (holding that district court erred in not applying the “reasonable certainty” test to a discretionary promotion). [read post]
7 Jan 2020, 7:26 am
After Pfizer initiated legal proceedings, Roche de-designated the UK from all relevant patent families. [read post]
2 Jan 2020, 9:25 am
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
20 Dec 2019, 6:33 am
For example, “in 2014, Pfizer paid for a study of its rheumatoid arthritis drug Xeljanz [tofacitinib],” in which its drug “came out on top,” but the study did not include “the treatment experts consider the most effective. [read post]
11 Dec 2019, 5:24 am
” In Pfizer Inc. v. [read post]
7 Nov 2019, 8:10 pm
Companies declining included Bristol-Myers Squibb, 7.9%; Pfizer, 6.9%; and Bayer AG 4.9%. [read post]
29 Oct 2019, 12:46 pm
Lourdes Delgado-Cheers has been appointed a Global Ombuds at Pfizer and based in Denver. [read post]
4 Oct 2019, 10:59 am
Pfizer, Inc., 457 N.J. [read post]
27 Sep 2019, 9:15 am
She has worked in the Ombuds Office at Pfizer since 2011. [read post]
27 Sep 2019, 6:00 am
Pfizer became the sole supplier of the active ingredient to Flynn; Pfizer raised the price and Flynn did as well (and then some). [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
17 Sep 2019, 9:37 am
Department of the Interior), Lourdes Delgado (Pfizer) and Zach Ulrich (Colorado Student Loan Ombudsperson). [read post]
13 Sep 2019, 2:58 am
Choice between federal and state courts implicates fundamental questions of fairness [Eric Alexander, Drug and Device Law on Supreme Court certiorari petition in Pfizer v. [read post]
12 Sep 2019, 5:44 pm
In 2017, Pfizer Inc. [read post]
10 Sep 2019, 8:03 pm
More recently, in Pfizer, Inc. v Arch Ins. [read post]
5 Sep 2019, 10:59 am
Months later, this forced Pfizer to put a black box warning on their drug label. [read post]
29 Aug 2019, 11:59 pm
Other similar cases followed the Italian Aspen case: see the decision of the UK Competition and Markets Authority (CMA), dated 7 December 2016, where the CMA found that Pfizer and Flynn have each abused their respective dominant position by imposing unfair prices for phenytoin sodium capsules manufactured by Pfizer (decision in case CE/9742-1). [read post]
26 Aug 2019, 4:15 am
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center... [read post]
